News

The new access avenue aims to enable physicians to use a wireless personal digital assistant (PDA), BlackBerry or smartphone to remotely access health information resources in real-time from

Proligo, a global supplier of key genomics research tools including custom DNA, custom RNA and phosphoramidite raw materials used for DNA and RNA synthesis, had 2004 sales of

Efficacy results with indiplon MR tablets demonstrated a highly statistically significant and clinically relevant improvement on the primary endpoint of patient reported total sleep time, as compared to

Using its integrated chemical and pharmaceutical development platform, EVOdevelop, Evotec OAI will complete the full validation of the process to AMD 3100, including process R&D, analytical work and

Diatos NV focuses its research on anticancer prodrugs, based on one of Diatos’s two core technology platforms, known as tumor-selective prodrug technology (TSP). The funding of E650,000 over

One of the studies, MSI-1256F-208, is a phase II trial designed to evaluate the effects of three different doses of squalamine in combination with an initial Visudyne treatment.

The primary endpoint was to increase platelet counts by 20,000 at 48 hours after dosing. Platelets perform a critical role in the body’s blood clotting system and low

The six month priority review for the supplemental new drug application (sNDA), sets the prescription drug user fee act (PDUFA) date to June 10, 2005. Solvay Pharmaceuticals holds

In the transaction, Cornerstone BioPharma will transfer the Humibid family of products, including over-the-counter (OTC) medications and prescription strength products to Adams Laboratories. In exchange, Adams Laboratories will